GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

Q1 2025 Earnings Call Transcript April 30, 2025 GSK plc beats earnings expectations. Reported EPS is $1.13, expectations were ...

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as ...

She said GSK also worked during Haleon's demerger in 2022 to "reset" its supply chain "for regional resilience and dual sourcing". So new steps to dual source for certain markets are not needed ...

offsetting lower vaccine sales on weak demand in the U.S. GSK plans to bring five new specialty medicines to market this year, including a comeback of previously withdrawn multiple myeloma ...

LONDON (AP) — LONDON (AP) — GSK plc (GSK) on Wednesday reported first-quarter earnings of $2.04 billion. The London-based company said it had profit of $1 per share. Earnings, adjusted for one ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

The company's partnerships and licensing deals will also be of interest, as GSK continues to complement internal R&D with external innovation. Any new collaboration announcements or progress updates ...

Drugmaker GSK (GlaxoSmithKline ... and the acquisition of a promising new oncology asset. “This momentum, together with the strength of our portfolio and proven ability to drive operating ...